Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma

Oncology

Volumn 58, Issue 1, 2000, Pages 66-74

  Hasegawa, Tadashi ^a,b   Yokoyama, Ryohei ^a   Lee, Yoon Hwan ^a   Shimoda, Tadakazu ^a   Beppu, Yasuo ^a   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Histological grading; MIB 1; p53; Prognosis; Soft tissue sarcoma

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; STATISTICAL ANALYSIS; TISSUE NECROSIS;

EID: 0033987998     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012081     Document Type: Article

References (34)

1. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, Mandard AM, Vilain MO, Jacquemier J, Duplay H. Sastre X, Barlier C. Henry-Amar M, Mace-Lesech J. Contesso G: Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996;14:869-877.
2. Toma S, Hohenberger W, Palumbo R, Schmidt O, Nicolo G, Canavese G, Badellino F: Soft tissue sarcomas in adults; in Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds): Prognostic Factors in Cancer. Berlin, Springer, 1995, pp 138-148.
3. Sobin LH, Wittekind C: UICC: TNM Classification of Malignant Tumors, ed 5. New York, Wiley-Liss, 1997, pp 106-109.
4. Markhede G, Angervall L, Stener B: A multivariate analysis of the prognosis after surgical treatment of malignant soft tissue tumors. Cancer 1982;49:1721-1733.
5. Costa J, Wesley RA, Glatstein E. Rosenberg SA: The grading of soft tissue sarcomas: Results of clinicohistopathologic correlation in a series of 163 cases. Cancer 1984;53:530-541.
6. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C: Soft-tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42.
7. Tsujimoto M, Aozasa K, Ueda T, Morimura Y, Komatsubara Y, Doi T: Multivariate analysis for histologic prognostic factors in soft tissue sarcomas. Cancer 1988;62:994-998.
8. Jensen OM, Hogh J, Ostgaard SE. Nordentoft AM, Sneppen O: Histopathological grading of soft tissue tumors: Prognostic significance in a prospective study of 278 consecutive cases. J Pathol 1991;163:19-24.
9. Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M: Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer 1992;70:2816-2822.
10. Guillou L, Coindre JM, Bonichon F, Bui NB, Terrier P, Collin F, Vilain MO, Mandard AM, Le Doussal V, Leroux A, Jacquemier J, Duplay H, Sastre-Garau X. Costa J: Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997;15:350-362.
11. Donhuijsen K: Mitosis counts: Reproducibility and significance in grading of malignancy. Hum Pathol 1986;17:1122-1125.
12. Baak JPA: Mitosis counting in tumors. Hum Pathol 1990;21:683-685.
13. Quinn CM, Wright NA: The clinical assessment of proliferation and growth in human tumors: Evaluation of methods and applications as prognostic variables. J Pathol 1990; 160:93-102.
14. Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, Ono K, Matsumoto K: Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989;63:1607-1611.
15. Choong PFM, Akerman M, Willen H, Andersson C, Gustafson P, Baldetorp B, Ferno M, Alvegard T, Rydholm A: Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation - A marker of metastasis? APMIS 1994;102:915-924.
16. Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF. Cordon-Cardo C: Prognostic implication of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst 1994;86:549-554.
17. Yang P, Hirose T, Hasegawa T, Seki K, Sano T, Hizawa K: Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma. Cancer 1995;76:618-625.
18. Levine EA, Holzmayer T, Bacus S, Mechetner E, Mera R, Bolliger C, Roninson IB, Das Gupta TK: Evaluation of newer prognostic markers for adult soft tissue sarcomas. J Clin Oncol 1997;15:3249-3257.
19. Heslin MJ, Cordon-Cardo C, Lewis JJ, Woodruff JM, Brennan MF: Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer 1998;83:490-497.
20. Jensen V, Brandt Sorensen F, Bentzen SM, Ladekarl M, Steen Nielsen O, Keller J, Jensen OM: Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: A retrospective immunohistological study including 216 soft tissue sarcomas. Histopathology 1998;32:536-546.
21. Rudolph P, Kellner U, Chassevent A, Collin F, Bonishon F, Parwaresch R, Coindre JM: Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study. Am J Pathol 1997;150:1997-2007.
22. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994;54:794-799.
23. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H: Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. Cancer 1994;73:2499-2505.
24. Nakanishi H, Ohsawa M, Naka N, Uchida A, Ochi T, Aozasa K: Immunohistochcmical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: Their correlations with prognosis. Oncology 1997;54:238-244.
25. Würl P. Meye A, Berger D, Bache M, Lautenschläger C, Schmidt H, Kalthoff H, Rath FW, Taubert H: Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas. Diagn Mol Pathol 1997;6:249-254.
26. Kuratsu S, Aozasa K, Myoui A, Tsujimoto M, Ueda T, Uchida A, Hamada H, Ono K, Matsumoto K: Prognostic significance of argyrophilic nuclear organizer staining in soft-tissue sarcomas. Int J Cancer 1991;48:211-214.
27. Dreinhofer KE, Akerman M, Willen H, Anderson C, Gustafson P, Rydholm A: Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: Prognostic value in 48 patients. Int J Cancer 1994;59:379-382.
28. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-363.
29. Enzinger FM, Weiss SW: Soft Tissue Tumors, ed 5. St. Louis, Mosby, 1995.
30. Gerdes J: Ki-67 and other proliferation markers useful for immunohistochemical diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1990;1:199-206.
31. Rudolph P, Peters J, Lorenz D, Schmidt D, Parwaresch R: Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens. Hum Pathol 1998; 29:1216-1222.
32. Ravaud A, Bui NB, Coindre JM, Lagarde P, Tramond P, Bonichon F, Stockle E, Kantor G, Trojani M, Chauvergne J, Maree D: Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials. Br J Cancer 1992;66:961-969.
33. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
34. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988;8:531-539.